Zdrowie i gospodarka · 26/08/2025
FDA Clears Heparin Sodium Products for Approval via Abbreviated New Drug Applications
The FDA has determined that four Heparin Sodium products were not withdrawn from sale due to safety or effectiveness concerns, paving the way for their approval through abbreviated new drug applications.